1

1 2

COMPANY PROFILE

FDC, formerly known as FairDeal Corporation, has been in 4the pharmaceutical business for almost seven decades now. FDC 5Limited, among India's leading pharmaceutical companies. ince 6inception in !"#$, she has made steady progress to become a 7global company. he operates world%class manufacturing and 8&'D facilities in India, and we also e(port to over )* countries, 9including the + , outh ,frica, +.-., .urope, /apan and more. 100his is way of ensuring that every patient who needs medicines 11finds us easily. 0oday, FDC is the largest producer of 1& the 12world over.
3

2ith a modest beginning in !"#$ % marketing vitamins and a 14range of prescription formulations % FDC set up its first 15formulations manufacturing facility in !"3". ubse4uently, in !"$#, 16FDC pioneered the manufacture of speciali5ed ophthalmic 17formulations in India. In !"67, FDC initiated the concept of 1ral 18&ehydration alts 81& 9. 0oday its brand '.lectral', commands 19more than 6*: market share in this segment, an impressive 20achievement in a fiercely competitive market. FDC's ,;I plant at 21&oha 8<aharashtra9 was among the first few ,;I facilities in India 22to get + %FD, approval in !"=3. ince then, FDC has to its credit 23a number of new molecules, introduced for the first time in the 24nation.
13

FDC e(ports to over )* countries, including advanced 26markets such as the + , +-, outh ,frica, and /apan. ,s an 27integrated pharmaceutical company > with world%class ,;I and 28formulation capabilities > she offers a wide range of formulations 29as well as ,;I's. ?esides her oral solid and oral li4uid formulations, 30her e(pertise in ophthalmic and 1ral &e%hydration alt 81& 9 31dosage forms gives us e(tensive reach and penetration across 32continents. @er competence in product development and 33manufacturing, built over several years of relentless efforts, has 34made us a preferred supplier to global customers including non% 35profit organi5ations like +AIC.F, ID,, < F and ; I.
25 2 3Page ! 4

IA%;L,A0 0&,IAIAB &.;1&0%7**=

36 37 38

HISTORY

2ith a modest beginning in !"#$ % marketing vitamins and a 39range of prescription formulations % FDC set up its first 40formulations manufacturing facility in !"3". ubse4uently, in !"$#, FDC pioneered the manufacture of 42speciali5ed ophthalmic formulations in India.
41

In !"67, FDC initiated the concept of 1ral &ehydration alts 4481& 9. 0oday its brand '.lectral', commands more than 6*: 45market share in this segment, an impressive achievement in a 46fiercely competitive market.
43

FDC's ,;I plant at &oha 8<aharashtra9 was among the first 48few ,;I facilities in India to get + %FD, approval in !"=3. ince 49then, FDC has to its credit a number of new molecules, introduced 50for the first time in the nation
47 51 52 53 54 55 56 57 58

6 7Page 7 8

IA%;L,A0 0&,IAIAB &.;1&0%7**=

59 60MILESTONE

10 11Page # 12

1936
13

<r. ,nand Chandavarkar set up FairDeal Corporation 8FDC9 to import drugs, infant foods and surgical IA%;L,A0 0&,IAIAB &.;1&0%7**= appliances for distribution in India Formulation plant established in /ogeshwari, <umbai FairDeal introduced Canmycetin .ye Drops > starting point for its ophthalmic and .A0 range .lectral introduced by FairDeal > a result of pioneering work in rehydration therapy FairDeal's &'D facilities obtain recognition from the Bovt. of India ,ctive ;harmaceutical Ingredient commissioned at &oha, <aharashtra 8,;I9 plant

1949 1963

1972

1974

1977

1984

Foods division set up for manufacture of speciali5ed infant foods at &oha First + FD, approval of ,;I plant at &oha FairDeal Corporation 8;vt.9 Ltd. was renamed FDC ;vt. Ltd. and thereafter FDC Limited Commissioned a formulation ,urangabad 8<aharashtra9 ;lant at 2aluD,

1985 1986

1987

1989 1991

?egan commercial production of Flurbiprofen ?iotechnology research center set up at 2aluD. tarted production of 0imolol <aleate 8,;I9. Aational ,ward from the Council of cientific &esearch and Industry for Indigenous &'D of Flurbiprofen and 0imolol FDC became the first company in India to introduce ophthalmic in blow%fill%seal packs, which optimi5e sterility and are highly user friendly FDC established a speciali5ed ' dedicated field force to promote its ophthalmic specialties FDC awarded E.(port @ouse' status ;ublic issue of 7$, 7=, 7** e4uity shares of &s. !* each at a premium of &s. "* each +-%<@&, approval for ophthalmic facility at 2aluD Formed a /C in +First +-%<@&, approval for oral solids facility at Boa &e%organi5ed Indian marketing operations into #

1992

1994

1996

1996 1996

1998 14 15Page 3 1999 16 2002 2003

62 63 64 65 66

17

IA%;L,A0 0&,IAIAB &.;1&0%7**=

VISION AND MISSION

68 69Visio 700o be a customer%oriented organi5ation that value%adds its way to 71leadership through people, effective communication channels and 72technology

management.

74 75Missio 76Customer satisfaction and employee empowerment in tandem with 77innovation and e(cellence are the key factors propelling A;0 78forward. 0o work together with our customers to help them achieve 79their goals. 1ur success lies in your success 80!o"# 81It is Endeavour $o %&&$ $'&

&&(s " ( )&*+i)&%& $ o, o+) 82-+s$o%&)s ./ o,,&)i 0 s",& 1 &,,i-"-io+s *+"#i$/ 2)o(+-$s 833'i-' %&&$ $'& -+))& $ )&0+#"$o)/ )&*+i)&%& $s "$ "## 84$i%&s4 E"-' i (i5i(+"# is -o%%i$$&( $o i%2#&%& $ 1 85-o s$" $#/ i%2)o5& $'& *+"#i$/ o, o+) 2)o(+-$s 1 s&)5i-& 86$')o+0' -o $i +o+s +2 0)"("$io o, *+"#i$/ %" "0&%& $ 87s/s$&%s6 $&-' o#o0/6 $)"i i 0 1 s&#, (&5&#o2%& $6
88 89 90 18 19Page ) 20

21

IA%;L,A0 0&,IAIAB &.;1&0%7**=

91 92

ACHIEVEMENT

93FDC received the Fuality .(cellence ,ward from GIndian Drug 94<anufacturers' ,ssociationG 8ID<,9 in !""# and !""3. 95For breakthrough &'D efforts, FDC has been awarded the 96GAational ,ward for &'D effort in the industryG by the Department 97of

cientific ,ffairs, <inistry of Commerce, and Bovt. of India.

98,part from being 2@1%B<; certified, FDC's ,;I and formulation 99manufacturing facilities are approved by regulatory authorities from 100all over the globe, including +- <@&,, + 101and <CC 8 outh ,frica9. 102FDC recently received the prestigious CE certification

FD,, ,ACI , 8?ra5il9,

FDC recently received the prestigious C. certification for yet 104another productH
103 105 106

SODI7M HYAL7RONATE E/& D)o2s 8@ymoist .ye Drops9.

FDC earlier obtained two C. markings in the regulated 107.uropean market forH
108 109

HYPROMELLOSE E/& D)o2s ' I8L79E E/& D)o2s

FDC successfully received re%certification for ISO 9001:2000 1101 ISO 13485:20034 0his re%certification is awarded for maintenance and 112implementation of Fuality <anagement ystems relating toH 113Design, Development, manufacturing and ale of ;harmaceutical 114;roducts as well as <edical Devices.
111 115 116FDC;s Ciprofloxacin Ophthalmic Solution 117$'& U.S. FDA
)&-&i5&s "

nod ,)o%

22 23Page $ 24

25

IA%;L,A0 0&,IAIAB &.;1&0%7**=

FDC Limited, leaders in the field of ophthalmology, achieves 119another milestoneIII

118

FDC Limited has now received an approval from the +. . 121FD, for its ,bbreviated Aew Drug ,pplication 8,AD,9, 122Ciproflo(acin 1phthalmic olution. Ciproflo(acin 1phthalmic 123 olution is a broad spectrum antibiotic used for occular surface 124infections.
120

,s announced earlier the Company had recently received 126approval for 0imolol <aleate 1phthalmic olution. ,nother ,AD, 1271flo(acin 1phthalmic olution is in the final stages of approval.
125 128 129 130 131 132 133 134 135 136 137 138 139 140 141M)4 A " ( L4 C'" ("5")<") 8!"*)%!")"9 26 27Page 6 28

9OARD OF DIRECTOR

29

IA%;L,A0 0&,IAIAB &.;1&0%7**=

142 143

Founder

144M)4 R"%("s A4 C'" ("5")<") 8!"##%7**!9 145 Chairman .meritus 146 147DIRECTORS 148 149M)4 <ohan ,. Chandavarkar 150 8Chairman and <anaging Director9 151M)4 ,shok ,. Chandavarkar 152M)4 Aandan <. Chandavarkar 153 8/oint <anaging Director9 154M)4 ,meya ,. Chandavarkar 155 8Ceased to be a wholetime director w.e.f ,pril *!, 7**6, 156 continues to be a non%e(ecutive director9 157M)4 Birish C. haredalal 158Dr. atish . +grankar 159Dr. &ahim @. <ulDiani 160Dr. Aagam @. ,tthreya 161Dr. &avindra J. Chittal 162 163COMPANY SECRETARY 164Ms4 halini -amath 165

30 31Page = 32

33

IA%;L,A0 0&,IAIAB &.;1&0%7**=

166 H7MAN 167 168

RESO7RCE DEPARTMENT 1 POLICIES =PERSONNEL>

In the FDC ;@,&<,C.+0IC,L LI<I0.D, this 170department is managed by the deputy personnel manager and 171personnel assistant reporting to him. ecurity officer reporting to 172the personnel manager.
169 173V")io+s ,+ -$io s o, $'is (&2")$%& $ is "s ,o##o3s ? 1741] 0ime keeping 1752] Man power planning 1763] Selection and recruitment of personal 1773K alary and wages administration 178)@ Industrial relations 179$K ;rovision of employee services 1806K .mployee education, training and development 1818] Employee evaluation 1829] Organizing raining !rogrammed 183!*K Employee motivation 184 1851@ Ti%& <&&2i 0 ?

0his is the important function of this department. For 187accurate record of the workers attendance. Like, times of the 188entering and leaving, time records are used. .very work man on 189enter the item cards bearing his own number from the rack, the 190card arrangement is numerically and inserts the same through a 191slow in the time records clock which is installed in this department. 1920he time cards disclosed the attendance of the workman, which is 193entered in attendance register by personal assistant. ,t the end of 194the month the personal assistant calculates and make up the
186 34 35Page " 36

37

IA%;L,A0 0&,IAIAB &.;1&0%7**=

195workmanLs pay according to the time cards and new cards on the 196racks replace the old cards. 197

0he company proposed to the introduce new model of 199clutches suitable for the new generation of fuel efficient vehicles, 200which are being introduced in the country, in collaboration leading 201vehicles manufacturers from all over world. 0he company has 202already started negotiation with the Indian vehicle manufacturers. 2030he company therefore looks forwards with optimism the future 204prospects.
198 205 2062@ M" 207

2o3&) 2#"

i 0?

0he personnel manager plans manpower re4uired for the 208work according to the 4uality of the work re4uired. ;eriod for 209completion of the work and talent re4uired for the completion of the 210work.
211 2123@ S&#&-$io 213

" ( R&-)+i$%& $ o, P&)so "# ?

ources used for purposes of recruitment of the personnel >

214,K ,dvertisement of vacancies in news papers. 215?K .mployee recommendation. 216CK Aotification of vacancies to employment e(change.

0he purpose of selection of the personnel. 0he personal 218manger makes various test, attitude test, general knowledge etc.
217

0he personnel manager takes personnel interviews and 220select prospective employees.
219

0he personnel manager fi(ed this term of employment of 222who are engaged. @e is signs the workers to different department 223according to the suitability.
221 224 38 39Page !* 40

41

IA%;L,A0 0&,IAIAB &.;1&0%7**=

2254@ S"#")/ " ( A"0& A(%i is$)"$io 226

0he personnel assistance maintains a record of the number 227of workers employed in each department or section hrs. 2orked 228by each worker is ascertained at the each week Mmonth. 0he 229personnel assistant sends this data to the account department and 230account department prepare wage sheets indicating the gross 231amount due to the each workers and the net amount pay able to 232him after deduction for house rent, advances fines, insurance and 233medical treatment, etc. the cash payment at the end of the month. 2340he wage voucher prepared for the each worker. 0he Leaves 235facilities are recording to . 0 regulation. 0he condition for 236;rivilege Level N;LK is up to 73* working days and Casual Leave 237NCLK is three days in the year fi(ed for all.
238 2395@ R&-o)( o, $'& E%2#o/&&s ?

0his department maintains detailed record of each 241employee of company, personal folder, service, letters, etc.
240 242 2436@ M"i $& " -& o, Dis-i2#i & ?

0he personal department maintains discipline the employee 245and changes to faster team spirit the employees.
244

upervise the term of employment. 247- ,dopt and enforce factory rules. 248- Control the labour attendance. 249- If necessary gives memos and charge sheets. 250- ,ttends to grievances and complaints of workers. 251- Impose fines and make dismissals if necessary. 252- 7@ A&#,")& o, Ao)<&)s ? 253 In this department, welfare of workers and works for 254maintaining good industry. 0his department renders valuable 255service and interested of the works considerable by lending their 256co%elected representative of work rest pauses, discipline, technical
24642 43Page !! 44

45

IA%;L,A0 0&,IAIAB &.;1&0%7**=

257training, promotions schemes and other condition of work with 258factory.

For the safety of workers following things are considered 260by this department !K ;rotection from occupational ha5ards.
259 2617K ;rotection from fire ha5ards. 262#K 2633K

afety training. upervision of safety regulation.

264)K Investigation. 265$K ;roper lighting and ventilation. 2666K 2ashing facility 267=K Cleanliness and temperature of the work shop. 268 269Fo) $'& ,"-i#i$/ 2)o5i(&( i 270-

$'is -o%2" / ?

Canteen facilities. 271- <edical service and health supervision. 272- &est room. 273- Co operative credit and co%operatives stores.
274 2758@ S&-+)i$/ S&-$io

? ecurity

2760he security officer reports to the personnel manager. 0hese four 277security guards are reporting to the security officer. 278section performs following function > 279 280 !. afe guarding companyLs property. 281 7. ;hysical check up of workman according to the standing order. 282 #. Checking and record of material come in and go from the

factory. 284 3. Issue of passes for visitor and proper record of it.
283 285

46 47Page !7 48

49

IA%;L,A0 0&,IAIAB &.;1&0%7**=

2869@ T)"i i 0 P)o0)"%%&( ? 287 288 289 290 291 292 293 294 295O.B&-$i5& 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312PLANT 313FDC

0o enhance the knowledge being a management trainee. 0raining in a multinational company like FDC ;@,&<,C.+0IC,L LI<I0.D gives the idea of huge management work having interlinks in the different countries. 0he training has given us idea of working of different department like production, stores, finance, personnel, marketing etc.

o, $'& T)"i i 0

0he basic obDective of the training was to get through the different management concept through production, personnel, finance as well as with the marketing department. ,lso we had an increase in knowledge of .ngineering through the managerial concepts. 0o apply the theoretical knowledge to learn the various aspects of management.

LOCATION 1 PLANT LAYO7T

P'")%"-&+$i-"# LTD4

50 51Page !# 52

53

IA%;L,A0 0&,IAIAB &.;1&0%7**=

314R&0is$&)&( O,,i-&

A(()&ss:

FDC LI<I0.D L0D ?%=, <IDC ,rea 2aluD % 3#! !#$ Dist. ,urangabad <aharashtra

*73* % ))33*6 M ))37"" M ))3"$6 315Co)2o)"$& H&"( O,,i-& A(()&ss: FDC Limited !37%3=, . C. &oad /ogeshwari 82est9 <umbai % 3** !*7 <aharashtra India *77 % 7$6=*$)7 M 7$6=7$)# M 7$6=7$)$ M 7$66)7=7 M 7$66)7=# M 7$6=)!6$ M 7$6=7)37 M 7$6=6)$= M 7$6"3#6"

T&#:

T&#:

316/1B. @2,&I ;L,A0, <+<?,I H

A(()&ss:

FDC Limited !37%3= . C. &oad /ogeshwari 82est9 <umbai % 3** !*7 <aharashtra India

317 318 319 320&1@, ;L,A0, <,@,&, @0&, H

54 55Page !3 56

57

IA%;L,A0 0&,IAIAB &.;1&0%7**=

A(()&ss:

FDC Limited, ;lot Ao. !" ' 7*M7 <IDC Industrial ,rea &oha % 3*7 !!$ Dist. &aigad <aharashtra India

321C.&A, ;L,A0 ,B1, I ' II ;L,A0 322C.&A,, B1, 8;L,A0 III9 323 IAA,& ;L,A0, <,@,&, @0&, 324+- ;L,A0

A(()&ss:

FDC International Ltd. !*, 0he 0anneries,.ast treet , 0itchfield, Fareham , @ampshire , ;1!3 3,& +nited -ingdom O33%!#7" =3! )$*

T&#:

1+0@ ,F&IC,

FDC , 8;0J9 Ltd. $", 2essel &oad , ?entley 1ffice ;ark , ?uilding no. 7, &ivonia, andton, /ohannesburg, &epublic of outh

,frica ,+&,AB,?,D 82,L+/9, <,@,&, @0&,

58 59Page !) 60

61

IA%;L,A0 0&,IAIAB &.;1&0%7**=

325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341

Dosage formsH terile 1phthalmic ;reparations in ?F % LD;. vials offering )ml, !*ml, !)ml and single dose vials 8units9 in *.)ml. Li4uid 1ral olutions, 1ral &ehydration alt ;owder, and .(ternal ;owder preparations. CapacityH
o o o o

#=.3 million vialsMyr 8 terile 1phthalmic9 ".$ million li4uid oral bottlesMyr 6#.7 million 1& sachetsMyr #.$ million e(ternal powder containersMyr

,pprovalsH P 2@1%B<;, <CC% outh ,frica, +-%<@&,, ,ACI , ?ra5il, + %FD,, I 1 "**!H7***, !#3=)H7**# +ni4ue 0echnologyH
o o o

?F technology for ophthalmic preparations FF technology for 1& preparations in sachets Integrated lines for manufacturing, filling, sealing and packing

62 63Page !$ 64

65

IA%;L,A0 0&,IAIAB &.;1&0%7**=

342 343

FDC P'")%"-&+$i-"# LTD4 88P#" $ L"/o+$

66 67Page !6 68

69

IA%;L,A0 0&,IAIAB &.;1&0%7**=

344 345

PROD7CTION 1 OPERATION DEPARTMENT

3460his Department is a @eart of 0he industry and thus plays a very 347important role in any organi5ation. In FDC ;harmaceutical Ltd. 348manufactured three different types of preparation, this are 349 350 351 352 353 354!.

!. 1phthalmic 7. ;owder #. Li4uid

O2'$'"#%i-: 8 0his is sterile preparation applicable for 355treatment of diseases related to eye, ear ' nose. 1phthalmic 356preparation re4uires very much care in manufacture process. 357<aintenance of sterile area is important factor in this preparation ' 358thus it is divide according to particle si5e asH 359 a9 Brade D > class !***** 360 b9 Brade C > class !**** 361 c9 Brade ? > class !***
362

It include following specific areaH 364E 5i)o %& $ ")&"H it is under grade D area, which computer 365devices to control pressure, temperature, humidity in production 366area.
363 367 368Ai) s'o3&)H It is a small bo( useful for transefer of raw material ' 369test material from outside to inside the production area. It consist 370of high speed fan on cutoff side of bo(, it is useful to avoid entry of 371foreign particle into the production area. 372 373Ao)<&) C'" 0& Roo%H 0his has separate entry for worker than 374other manufacturing area. 0his includes # types of dress for 375different Brade sterile area which completely close the worker. 376 a9 377 b9 378 c9 379

Brade D > class !***** % &egular Industry dress Brade C > class !**** > ?lue colour dress Brade ? > class !*** % 1range colour dress

70 71Page != 72

73

IA%;L,A0 0&,IAIAB &.;1&0%7**=

3800he process of ophthalmic preparation is carried out step by stepH 381 382 383 384 385 386 387 388

,s per ?<& raw material is ordered

&aw material enter from store department to ophthalmic area through air shower

,s per ?<& the raw material is mi( in mi(ing chamber 390 80here are two types of container which have capacity of !*** ' 391 )**Lt9
389 392 393

2ell prepared uniform solution is transfer to ,L; i.e. automatic 395 Li4uefier <achine 2hich is important instrument applicable for 396 Filling of olution ' Formation of ;lastic ?ottles. It is as a fully 397 automatic machine, at a time !* uniform bottles are formed ' filled 398 which are present in one card.
394 399 400

0his card is deflashed by Deflashed Card <achine i.e. Filled 402 bottles are separate from complete card. 1ne card consists of !* 403 bottles.
401 404 405 406 407 408 409 410 411 412 413 414 415 416 74 75Page !" 76

0hen Capping is done by automatic capping machine.

0he capped then ;an ;ac Controlling <achine for Labeling ;rinting of mfg ' e(piry date with price which simultaneously laminate the bottles in ploythine paper. ' it is ready for carton packing ' ?o( ;acking.

0hen preparation is ready for e(port

77

IA%;L,A0 0&,IAIAB &.;1&0%7**=

417 418 7. 419 420

Po3(&) s&-$io H

0he powder preparation include very important 421productH 1& <ycoderm 8Dusting powder9 etc. which are 422applicable f o) I $&) "# "s 3&## "s &C$&) "# +s&4 423T'is is -o%2#&$&#/ ()/ 2)o(+-$ %" +,"-$+)&( i .+#< 4242)&2")"$io 4 T'& 2)o(+-$s ")& 2"-<&( i 3&## s&"#&( 4252#"s$i- 2o+-' 3i$' "--+)"$& "%o+ $ o, 2o3(&)4 426T'& %"i 2)o(+-$ o, -o%2" / is E#&-$)"# =O)"# 427R&'/()"$io S"#$s>6 for which FDC. Ltd "))" 0&( N"+$" 428MiC&) in manufacture area i4&4 ,o) %iCi 0 o, -o $& $ o, 429&#&-$)"# 1 5")io+s s$"-< .i with different capacities to 430store powder. 431,lso there are three types of %&-'" i-"# s$i))&) are 432present at different level 8I st , II nd floor).
433Other devices present in this section are:

434P"ss 9oC "

to transf er powder from one place o anot#er use for mi$ing in small amount use for %lending

435P#" &$o)/ MiC&) " 437D+s$ -o##&-$o) " 438 439 440

436O-$"0o "# 9#& (&) "

use for collecting dust from air& it is %eneficial for wor'er(

441 442 443 444 445 446 447 448 449 450 451 452 453ORS M" +,"-$+)i 0 P)o-&ss " 454
455

)ispensing of raw material

456 78 79Page 7* 80

81

IA%;L,A0 0&,IAIAB &.;1&0%7**=

*erification of raw material

457
458

459 460
461

Milling

462 463
464

Sifting

465 466
467

Mi$ing +ul' sample for analysis ,nloading into stac' %in

468
469

470
471

472 473
474

-uarantine

475 476
477

.elease from -uality assurance

478 479
480

)ispensing of !ac'ing Material

481 482
483

*erification

484 485
487 488
486

ransfer into !ac'ing /all

489 490
491

Filling by Auto pack filled & seal machine

492#.

Li*+i( (&2")$%& $ H 493 0he name itself includes the li4uid preparation, which is 494taken orally. <ostly water is use as a main constituent of 495preparation in which drug is mi(ed in accurate amount and this is 496filled in bottles. 0he process of bottle filling ' packing is occurring 497under following machineH 498 a9 ?ottle washing machine H 499 It is Ist step of process where bottles are washed in 500 both side i.e. from inside ' outside. 501 Linear bottle washing machine > washing cycle is 502 given under
82 83Page 7! 84

85

IA%;L,A0 0&,IAIAB &.;1&0%7**=

503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531In 533

Inner washing by compressed air Ist wash wither cycle purified water IInd wash with recycle purified water IIIrd wash with fresh water 2ashing with *.7u filtered air

1uter wash with li4uid L! ' L7 b9 <onoblock ?ottle Filling machine H It is = head li4uid filling fully automatic machine, applicable for filling li4uid. 0his accurately counts volume of filling li4uid which have to fill in bottle. imultaneously, capping process is occurring where cap is sealed on mouth of bottle. c9 Cisual Inspection 0able H 0his machine is of company ;harmalab, under which bottles are analy5ed. 2here volume ' foreign particles are check visually under black ' white background.

d9 ,uto <easure Cup dispensing <achine H 0his machine is applicable for capping of cup on sealed bottles. Cup is nothing but the plastic volumetric cap which is slightly pressed on sealed cap. e9 &ecovery container H 0he li4uid of waste bottle is collected and passed through this recovery container.

the industry there are number of systems are present 532this areH

86 87Page 77 88

89

IA%;L,A0 0&,IAIAB &.;1&0%7**=

534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562

!. 7. #. 3.

2ater system Compressed air system ,ir Conditioned system @ot air system

14 A"$&) s/s$&%
0his is very important system of industry which supply purified water, distilled water, potable water for industrial application. 0he process of purification is carried out in company itself by different instrument. 7. Co%2)&ss&( "i) S/s$&% H 0his supply air with high speed which is useful for washing, cleaning ' drying of instrument.

34 Ai) Co (i$io &( s/s$&% : 0his maintained the cool temperature in the room. 44 Ho$ "i) s/s$&%
0his supply hot air for drying of bottle.

OR!ANIDATION STR7CT7RE
*ice !resident

90 91Page 7# 92

93

IA%;L,A0 0&,IAIAB &.;1&0%7**=

563 564 565 566 567 568 569 <ark.<anager 570 571 572 573 574 @ead ;L I 575 576 577 578 579 @ead ;lant II @ead ;lant III @ead ;lant IC
!rod& Manager 0M( 1inance 0M 2ogistics 0eneral Managing )irector

PROD7CTS

580FDC e(ports to over )* countries, including advanced markets 581such as the + , +-,

outh ,frica, and /apan. ,s an integrated 582pharmaceutical company > with world%class ,;I and formulation 583capabilities > we offer a wide range of formulations as well as 584,;I's. ?esides our oral solid and oral li4uid formulations, our 585e(pertise in ophthalmic and 1ral &e%hydration alt 81& 9 dosage 586forms gives us e(tensive reach and penetration across continents. 5871ur competence in product development and manufacturing, built 588over several years of relentless efforts, has made us a preferred
94 95Page 73 96

97

IA%;L,A0 0&,IAIAB &.;1&0%7**=

589supplier to global customers including non%profit organi5ations like 590+AIC.F, ID,, < F and ; I. 5912ith over #** product registrations in place across the ,mericas, 592CI , ,frica, ,sia and the .+, FDC is eminently e4uipped to 593service these markets. 594FDC's international coverage, in terms of products registered and 595under registration, is as followsH

RE!ION

FORM7LATIONS RE!ISTERED 7NDER RE!ISTRATION 77 #" =" " 7$ !*

CI

3$ "" !77 ) !) =

,F&IC, , I, ;,CIFIC .+ 1+0@ ,<.&IC, A1&0@ ,<.&IC,

596 597 598

599IMPORTANT PROD7CTS 600E#&-$)"# =O)"# R&'/()"$io

:-

S"#$s> 601until the seventies, dehydration in India was treated with IC fluids. 6020his re4uired patients suffering from dehydration to be 603hospitali5ed, which made treatment difficult, inaccessible and 604e(pensive, especially for people living in rural India.

98 99Page 7) 100

101

IA%;L,A0 0&,IAIAB &.;1&0%7**=

605In !"67, FDC introduced 1ral &ehydration

alts under its brand 606name, .lectral, which revolutioni5ed the treatment of dehydration 607by using the oral route. In effect, the new delivery mechanism 608made treatment of dehydration much more convenient and 609economical. ince then .lectral has been a life%savior, especially 610in rural areas where hospital facilities are scarce.
6110oday, FDC is the largest producer of 1&

the world over. ,n 612achievement made possible by understanding local needs and 613meeting global healthcare challenges.
614So/"# =N+$)"-&+$i-"#> 615FDC put another first under its belt with

oyal % India's first soya% 616based protein supplement. +ntil !"=3, lactose intolerant infants 617and adults simply had no alternative to milk protein. Identifying this 618gap, FDC developed and launched oyalH an e(cellent substitute 619for protein obtained from milk. 0hus, FDC became the first provider 620of a vital food for lactose intolerant infants.
6210oday,

oyal has evolved to ;rosoyal, a market leader in the 622infant food segment in India. , product of its own kind, ;rosoyal is 623also e(ported to many foreign markets.
624Co$")/# =Mois$+)iE&)> 625During the seventies, FDC pioneered the launch of a scientifically 626designed cold cream with Aatural <oisturi5ing Factors 8A<Fs9 for 627various dry skin conditions. For decades now, Cotaryl has been 628widely prescribed by dermatologists across the country, a feat now 629imitated by a number of 10C brands. Cotaryl continues to enDoy a 630respectable position in the prescription market. 631M/-o(&)% =D+s$i 0 2o3(&)> 6321ver three decades ago, FDC was the first to offer a rational 633topical formulation designed to provide cool comfort during certain 634skin conditions caused by the tropical climate. <ycoderm % a 635popular brand amongst family physicians is still a top%of%the%mind% 636recall product, an achievement that few 10C brands have been 637able to emulate.

102 103Page 7$ 104

105

IA%;L,A0 0&,IAIAB &.;1&0%7**=

638Di,i =A $i8."-$&)i"# -&,iCi%&> 639Qifi has always e(perienced phenomenal growth. Its first year 640turnover Dumped over !* times from &s. 7* million to &s. 7)* 641million. 0oday, after Dust three years, Qifi's turnover has crossed 642&s. )** million. It is India's number ! brand among anti%bacterial 643cefi(imes. 644 645 646 647 648 649 650 651 652 653 654 655 656 657?F

DEPARTMENT F7NCTION
TECHNOLO!Y

8 tate%of%the%art ophthalmic technology9 658?eing the first company in the country to start manufacturing 659ophthalmic dosage forms, FDC has maintained its leadership 660position in the ophthalmic segment in India.
661In ophthalmic, sterility is paramount. In an effort to provide patients 662with the highest degree of safety, FDC deployed the ?low%Fill% eal 106 107Page 76 108

109

IA%;L,A0 0&,IAIAB &.;1&0%7**=

6638?F 9 technology to package eye drops for the first time in India . 6642hat

is ?F technologyR 665?F technology automates the entire process of blowing the 666plastic pack 8vial9 into the re4uired shape, filling the pack with the 667eye drops, and then sealing the pack. 0he result is a sterility% 668ma(imi5ed product, which is !**: safe and ready for use.
669In addition, FDC is the only company that manufactures a wide 670range of ophthalmic dosage forms in single%use packs, which are 671absolutely preservatives free. 0his is keeping in mind long%term 672users who can be adversely affected by preservatives in their eye 673drops. 674,fter our first +

FD, inspection in !"=), we have undergone over 675#* e(tensive audits by regulatory authorities including the + % 676FD,, +-%<@&,, ,%<CC and ,ACI , 6778?ra5il9. <ost importantly, our facilities have been approved by 678these authorities on every occasion.
6791ur regulatory e(perience has refined our operating systems and 680proceduresS simultaneously, the function specific knowledge and 681competence of our employees continues to grow. 2e believe in 682offering only the best 4uality products, irrespective of whether the 683market is regulated or not. 2e have, therefore, built a strong track 684record of meeting with the most stringent regulatory re4uirements, 685enabling us to deliver high%4uality ,;Is and formulations at 686competitive prices % worldwide. 687 688 689Indian ;harmaceutical industry is identified as a growing & ' D 690hub. 691FDC recogni5ed For Dedicated Care has 692 693continuously contributed in giving cost effective products without 694Compromising on 4uality. Introduction of new products, innovation 695and 110 111Page 7= 112

RESEARCH 1 DEVELOPMENT

113

IA%;L,A0 0&,IAIAB &.;1&0%7**=

696improvement in the e(isting products are attributed to the efforts of 6970he &'D team backed by the e(cellent support structure of the 6981rgani5ation. 699 700a. Fo)%+#"$io s 701 702Jour Company has been making continuous endeavor to deliver 703efficient 704and cost effective products to the ultimate consumer. ,t places, we 705have revised the formulas and manufacturing process, resulting in 706cost 707savings and have developed alternative vendors for supply of raw 708material. 0he &esearch and Development Center of your 709Company 710continued to contribute to the 4uality of the e(isting products and 711the 712Company has been successful in launching variety of cost 713effective 714products. 7152e have launched several new products in this financial year. 716@ighlights of our new developments were as followsH 717 718a9 Developed Chloro4uine ;hosphate .ye drops 8+C Lube +nims9 719and 720Launched first time in India. 721 722b9 Developed three tablets formulations 8targeted for ,AD, 723submission9 724&eady for pilot bio%studies. 725 726c9

uccessfully launched Flucona5ole capsules in ,ustralian 727market 728including developing and e(ecuting the bulk pack.
729 730Jour Company has entered into a non%e(clusive license 731agreement with 732BIL.,D 114 115Page 7" 116

ciences Inc., for production and distribution of 0enofovir

117

IA%;L,A0 0&,IAIAB &.;1&0%7**=

733disopro(il fumarate 8tenofovir DF9 to ") low%income countries 734around 7350he world, including India. 0enofovir DF is sold by Bilead under 736the 737?rand name Ciread. In addition, this agreement also allows the 738<anufacture of commercial 4uantities of both ,ctive 739;harmaceutical 740Ingredient 8,;I9 and finished product. 741 742b. S/ $'&$i-s 743 744Development and commerciali5ation of technology was carried out 745for 746,;Is namely ?rimodine 0artrate, Dor5olamide @ydrochloride and 747Flucana5ole. Four Indian process patents for ,;Is and two +. 748patents 749for antifungal AC.s were also filed. 0hree AC.s belonging to 750anti%fungal class of compounds are currently in%vivo testing. 751 752c. N+$)"-&+$i-"#s 753 754 everal nutritional products are in the pipeline this year. & ' D is 755going on for releasing a low calorie sucralose based tabletop 756sweetener 757for calorie conscious people. , protein supplement with ten other 758essential nutrients in disc form for children, sports person is under 759development. ,lso your companies well renowned brand &.LI0.& 760D, will 761be re%launched in a pan masala flavor. 762. 9io$&-' o#o0/ 763 764,s reported to your earlier with regards to the technology 765agreement, 766entered into with the Israel based Company, your Company is 767actively 768involved in the process of introducing an additional 769chromatography 118 119Page #* 120

121

IA%;L,A0 0&,IAIAB &.;1&0%7**=

770step to obtain high 4uality consistent pure product. 0hereafter, the 771consistency batches will be submitted to the &eview Committee on 772Benetic

<anipulation for which we have already obtained 773permission from the Department of ?io%0echnology 8D?09.
774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803

F7ALITY CONTROL
Fuality control department plays important role any industry, dealing with 4uality aspects of product by performing various functions relating to 4uality as well. It also checks the standard limit of raw material, packing material ad finished products. 0hey perform various tests as per I;, + ; and ?;. 0hey check the purity of raw water. It consist of various sub departments, !. 0esting area 7. <icrobiological area #. Instrumental area 3. Control store area !. T&s$i 0 ")&"H % it involves testing of the sample. pecified tests are performed for the products, which are mention in 1;. 7. Mi-)o.io#o0i-"# ")&"H % It involves testing of the microorganisms and pathogens. <icroorganisms are ..coli, salmonnela, st. ,ureusS etc. It consists of instruments like inoculators, ?1D, Laminar airflow, 1ven for sterili5ation. Carious cultures are kept for inoculation for specific growth of microorganism lab. Fumigation is done when the microorganism grow in the culture, which is kept in the testing 5one. Fumigation is done by potassium permagnate and area is clean by !: teepol solution. ,fter fumigation, the microorganism present in the area is in limits. 34 I s$)+%& $s ")&"

122 123Page #! 124

125

IA%;L,A0 0&,IAIAB &.;1&0%7**=

804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840

+C cabinetH +C absorption encompasses analytical methods based upon measurements of lights absorption by substances in wavelength region from !"* to 3** nm. ,bsorption in +C region arises from electronic transitions within the molecule. 0here are two types of instrumentsS a9 ingle beam spectrometer. b9 Double beam spectrometer. +C spectrum serves as a confirmatory test of identify in support of analytical data and is also used as detector in @;LC. I0 is used for the analysis of 0LC plate. It contains # wavelengths. !. hort wavelengthsH 7)3 nm% red lights. 7. Long wavelengthsH #$* nm%green lights. #. Aormal visible lightsH visible yellow lights. FriabiltorH It is used to study the combined effects of abrasion and shock by utili5ing plastic chamber that revolves at 7)rpm. Dropping the tablets at a distance of $ inches with each revolution. Aormally, a preweight tablets sample is placed in the fribilator, which is then operated for !** revolutions and tablet that loss less than *.) %!: of their weights are generally considered as acceptable. .lectric sieve shakerH In these instruments the sieves are arranged in descending order i.e. larger sieve at bottom. Carious sieves are used are 7*T, 3*T, $*T, =*T, !**T. It is used for particle si5e separation. p@ meterH It is used for the preparation of buffer solution. 0he calibration is done at p@ 3, ", and !7. 0he p@ scale is a series of numbers. 0hese numbers e(press the degree of acidity or alkanity.

126 127Page #7 128

129

IA%;L,A0 0&,IAIAB &.;1&0%7**=

841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877

<agnetic stirrerH It contains $ locations for stirring on Uwhirmatic <ega +nitV which is used for preparation of uniform solutions. @;LC H high performance li4uid chromatography It is used to refer to those methods in which the separation takes place with a pack column. 0he packing material is the stationary phase, which may be solid or li4uid. 0he li4uid mobile phase is used as the elunt. In @;LC, the mobile phase is force through the column under high pressure. It is used in assay of new drugs, substitutes for older. -.F. apparatusH D< 0itration unitH Dynamic ?ioe4uivalence ;oint 0itration useful for point titration. 1smometerH use for measuring osmolarity ' osmolality. Digital flame ;hotometerH useful for estimation of amount of element sodium ' ;otassium in the present solution. ?rookfield CiscometerH Digital ;olari meterH useful for measuring optical rotation. Bas chromatographyH there are ) units present in 4uality control. 0his is useful for measuring concentration of drug in sample solution. Mi-)o.io#o0i-"# A)&" H 0he microbiological room is use for microbiological testing, which are very important for ophthalmic preparation as well as for ;owder ' li4uid preparation. 0his consists of following sub areaH Incubation areaH used for incubation. 0emperature re4uired 7* > #)*C, ?iological o(ygen demand incubator. Cooling cabins Digital ,ntibiotic Qone readerH use for operation ' calibration of digital antibiotic 5one reader.

130 131Page ## 132

133

IA%;L,A0 0&,IAIAB &.;1&0%7**=

878 879 880 881 882 883 884 885 886 887 888 889 890 891

1ther instrument present in <icrobiological area isH ,utoclaveH for storage testing slide, incubator at specific temperature for sterili5ation. ColorimeterH use for measuring concentration of drug in solution. ;anal CiewerH p@ meterH Compound <icroscopeH 3. Co $)o# S$o)& Roo%H 0his room is used to store the sample for FC and records. 0hey store the sample for Five year.

FINANCE PERFORMANCE

;rofit is the main obDective of any business. FDC LI<I0.D 893has very active Finance Department. Finance Department is very 894important to know the amount of profit earned or the amount of 895loss suffered during specified period of time. 0he Capital tructure 896of this company near about &s. !* cr. ,nd Capital budgeting also 897made on every year.
892

FDC LI<I0.D recorded sales growth of 76 : in domestic 899market over previous year, which constitutes "!: of the 900CompanyLs total sales. 901 0he margins were however under pressure due to price 902reduction in some of the CompanyLs leading brands and an all 903round increase in costs of active ingredients, utilities and 904marketing costs. 905 In addition, the investment income from dividends and gains 906on investments was substantially lower during the year, since the 907Company chose to deploy a maDor portion of surplus funds in safer 908li4uid mutual funds than in e4uity M e4uity related instruments, in 909view of e(treme market volatility. 910 2e are happy to report that Forbes ,sia 1ctober 7**6 911<aga5ine has ranked your company as one of the 7* publicly 9124uoted companies in the region with sales of less than W ! billion
898 134 135Page #3 136

137

IA%;L,A0 0&,IAIAB &.;1&0%7**=

913with solid top and bottom line gains and potentials for more 914success.

0he CompanyLs internal control procedures commensurate 916with its si5e and nature of business. 0he internal audit reports are 917regularly placed before 918the ,udit Committee for its review. 919 0he directors are pleased to present their report on the 920business and operations of your Company for the year ended 921<arch #!, 7**6.
915
922 923 924 925 926 927

138 139Page #) 140

141

IA%;L,A0 0&,IAIAB &.;1&0%7**=

928 929!ENERAL SHAREHOLDER INFORMATION

142 143Page #$ 144

145

IA%;L,A0 0&,IAIAB &.;1&0%7**=

930"4 A +"# !& &)"# M&&$i 0 931 DateH ,ugust 7), 7**6 932 0imeH !*.** a.m. 933 CenueH 2elcome @otel &ama International, &%#, 934 Chikalthana, ,urangabad 3#! 7!*, 935 <aharashtra 936 937.4 Di5i(& ( 2"/%& $ ("$& 938 939Interim dividend declared and paid by the board of directors X 940!**: on the paid up capital at its meeting held on <arch !*, 7**6, 941is hereby confirmed as the final dividend for the year 7**$%7**6. 942 943-4 S$o-< EC-'" 0&s 3'&)& #is$&( 9440he tock .(change, <umbai 8? .9 9450he Aational tock .(change of India Limited 8A .9 946 947(4 S$o-< Co(&: ? . % )#!)"", A . > FDC .F 948P&),o)%" -& o, $'& Co%2" /Gs s$o-< i -o%2")iso 949S& s&C 950

$o 9SE

951 952 953AoteH ?ased on monthly closing price of FDC and monthly closing 954inde( point of ? . ense(. 955Current price per shareH ? . A .
Statement Showing Shareholding Pattern

146 147Page #6 148

149

IA%;L,A0 0&,IAIAB &.;1&0%7**= #otal shareholding as a percentage of total num"er of shares

Categor code

!um"er of Categor of Shareholder Sharehold ers

#otal num"er of shares

!um"er of shares held in As As demateriali$ a a ed form percentag percentag e e of of%A&')( %A&'&C)

%A)

Shareholding of Promoter and Promoter )roup* +ndian 5ndividuals6 /indu ,ndivided 1amily +odies ;orporate Su" #otal%A) %()

3a4

11

727189:9

727189:9

37(98

37(98

3c4

8979<<<<

8979<<<<

29(<<

29(<<

(,

(**-.,/-/

(**-.,/-/

/0.12

/0.12

3oreign #otal Shareholding of Promoter and Promoter )roup %A)4 %A) %()&%A)%*) Pu"lic shareholding +nstitutions Mutual 1unds

(,

(**-.,/-/

(**-.,/-/

/0.12

/0.12

%')

( 3a4

89:9911

8989911

8(:2

8(:2

150 151Page #= 152

153

IA%;L,A0 0&,IAIAB &.;1&0%7**= 3%4 1inancial 5nstitutions 6 +an's *enture ;apital 1unds 5nsurance ;ompanies 1oreign 5nstitutional 5nvestors Su"-#otal %') %() !oninstitutions +odies ;orporate 5ndividuals 5ndividuals i( 5ndividual s#are#olders #olding nominal s#are capital up to .s 1 la'# ii( 5ndividual s#are#olders #olding nominal s#are capital in e$cess of .s( 1 la'#( 8 33822 33822 <(<2 <(<2

3d

1<1<

1<1<

<(<<

<(<<

3e4

1897<<<

1897<<<

<(99

<(99

3f4

1<

2:12899

2:12899

1(31

1(31

*0

(0(.0-01

(0.10-01

/.2,

/.2,

'*

3a4

1<:2

9928389

99<1387

:(<3

:(<3

3%4

88932

32139789

2811:2<9

19(79

19(79

55

8<

12:8<378

8:1<878

9(:7

9(:7

3c4

3;learin =ny g Ot# Mem%er er s4

113

3389:9

3389:9

<(18

<(18

154 155Page #" 156

157

IA%;L,A0 0&,IAIAB &.;1&0%7**=

3>.54

31:

1198399

11:8399

<(91

<(91

Su"-#otal %') %*) #otal Pu"lic Shareholding %')4 %')%()&%') %*) #O#A6 %A)&%') S#ares #eld %y ;ustodians and against w#ic# )epository .eceipts #ave %een issued )7A!8 #O#A6 %A)&%') &%C)

-.(-*

--2-*1.5

,55*.2*-

*1.(2

*1.(2

%')

-.(5-

/21-/,,/

/.2(,0/,

0/..*

0/..*

-.(21

(1(,/((.*

(200(1.*.

(.....

(.....

%C)

....

....

-.(21

(1(,/((.*

(200(1.*.

(.....

(.....

Categor code

!um"er of Categor of Shareholder Sharehold ers

#otal num"er of shares

!um"er of shares held in As As demateriali$ a a ed form percentag percentag e e of of%A&')( %A&'&C)

#otal shareholding as a percentage of total num"er of shares

956

957 958 959 960 158 159Page 3* 160

161

IA%;L,A0 0&,IAIAB &.;1&0%7**=

961 9629OOHS MAINTAINED 9Y THE FNANCIAL DEPARTMENT:

,s per the accounting rules, FDC ;@,&<,C.+0IC,L 964LI<I0.D. <aintains all the records in proper accounts books.
963 965 966?11967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992

<,IA0,IA.D ,&.H

!. 7. #. 3. ). $. 6. =.

Beneral ledger Cash ' ?ank book /ournal voucher ;urchase book ales book Loan to staff ledger uppliers ledger ;ersonal ledger.

&.BI 0.& H !. 7. #. 3. ). $. 6. ;urchase order register ales 0raveling e(penses register DD purchase register 0.D. . summery register Che4ue issue register 1ctori register

C1+C@.& H !. 7. #. 3. ). $. 6. <aterial purchase voucher Capital purchase voucher .(penses purchase voucher ?ank payment voucher Cash payment voucher Closing stock voucher 0raveling e(penses statement

162 163Page 3! 164

165

IA%;L,A0 0&,IAIAB &.;1&0%7**=

993 994 995 996 997 998 999 1000 1001

,ll these vouchers are entered in to various sub%ledgers In Beneral Ledger, there are # typesH sub%ledger, regular, outstanding ledger. <ainly sales and sales debit note, sales credit note, purchase credit note, che4ue receipt voucher, and Dournal voucher all the types of entries are taken as there is monthly closing company makes and prepare Beneral ledger and <ain ledger.

1002O9IECTIVES: 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022

!. 0o record the day to day financial position of the business. 7. 0o maintain accounts systematically as per the company ,ct. #. 0o know the amount profit earned or loss suffered during a particular accounting period. 3. 0o know the amount of ,ssets and Liabilities in the business on any particular Date. ). 0o review the progress of the companyLs business from year to year.

MARHETIN!

166 167Page 37 168

169

IA%;L,A0 0&,IAIAB &.;1&0%7**=

1023,s per 1&B%I<

tockiest econdary audit report for <arch 7**6 1024<,0, your Company registered a growth of !#: during the year 10257**$%7**6, as against the Indian pharma industry growth of 1026!3.#*:. Jour Company has maintained a market share of !.)*: 1027and its rank has been maintained at 77nd. Jour Company has 1028shown good performance in the western region. <ost of the 1029leading products continued to register e(cellent growth with the 1030flagship brand QIFI, which is now ranked as the !#th largest 1031pharmaceutical product in India as against !3th rank of last year. 1032?rand e(tension QIFI L?Y has been ranked #rd most successful 1033product amongst all the new products launched in the industry 1034during 7**$.
1035 1036During the year 7**$%7**6, your Company continued to introduce 1037innovative products which are being aggressively promoted in 1038various therapeutic categories which are as underH 1039 10400herapeutic Broup 1041 10421& 10431phthalmologicals 1044Dermatologicals 1045,nti%bioticsM 1046,nti%bacterials 1047@aematologicals 1048,nti%allergies 1049Aeutraceuticals 1050;ain management 1051Cardiovasculars 1052Qivast , ; 1053,nti%diabetics 1054Qiglim ;lus, 1055 1056 1057 1058

0rade Aame .ner5al 8&eady to drink product9 +.C. Lube Qocon Lotion Qilee%1Q, Q1% & 3**, Qorno usp., Qemi Clip%<F, Citcofer &al5al &eliter%D ,rflur #D, ,rflur %<& ynplatt, Qilos%@, Qivast%,<, Qoform &, Qiglim, Qiglim <,

Qilmet, Qipio, Qipio%<

CONCL7SION

170 171Page 3# 172

173

IA%;L,A0 0&,IAIAB &.;1&0%7**=

1059

For a <?, student a learning combination of theory and 1061practice is an invaluable asset, as this helps in understanding the 1062core principles of business by way of first hand e(periences. 0his 1063in plant training is a stepping stone, which will groom me for my 1064future in the Corporate 2orld.
1060

In ;lant%0raining helped me to understand all the functions, 1066which is going in the company. 0his training also helped me to 1067understand the managerial skills, which we study theoretically.
1065

It helped me to understand and know the e(act mechanism 1069of working of the various departments. Company should have 1070more e(perience and skilled workers ' with training center for it 1071employees.
1068

It gave the ideas about the e(act work done by the <anagers 1073and also about the vocation they do in contemporary.
1072

0hus, in plant training gave me a practical touch and useful 1075to clear out practical concept and gave a right direction to my 1076mind.
1074 1077 1078

1080 1081

174 175Page 33 176

177

IA%;L,A0 0&,IAIAB &.;1&0%7**=

1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 178 179Page 3) 180

S7!!ESTIONS
0o implement multi%skill inde( for employees ' to conduct

assessment development centers. Calue .ngineeringH 0o adopt new technologies those are introduced in the recent era of manufacturing. Calue ,nalysisH 0he price of products should be similar or less as compare to the competitorLs product ' should increase profit margin. ?enchmarking is done as per Aational market it should be done global market. 0o have marketing or customer care units on regional level in spite of having at state level.

9I9LIO!RAPHY

181

IA%;L,A0 0&,IAIAB &.;1&0%7**=

1108 11092eb

&eference

1110www.fdcindia.com 1111 1112?ook 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 182 183Page 3$ 184

&eference

Industrial <anagement by 1.;.-hanna

,nnual &eport of FDC ;harmaceutical Ltd4

185

IA%;L,A0 0&,IAIAB &.;1&0%7**=

1131 1132THANHIN! 1133 1134 1135 1136 1137 1138 1139 1142

YO7

LIF. is mostly froth ' bubble, 0wo things stad like stone Confidence is an another stu!!le Courage is our o"n #his courage $ confidence % have received from FDC &harmaceutical '#D.

186 187Page 36 188